Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

RNF4-Dependent Oncogene Activation by Protein Stabilization.

Thomas JJ, Abed M, Heuberger J, Novak R, Zohar Y, Beltran Lopez AP, Trausch-Azar JS, Ilagan MXG, Benhamou D, Dittmar G, Kopan R, Birchmeier W, Schwartz AL, Orian A.

Cell Rep. 2016 Sep 20;16(12):3388-3400. doi: 10.1016/j.celrep.2016.08.024.

2.

Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.

Trausch-Azar JS, Abed M, Orian A, Schwartz AL.

J Cell Physiol. 2015 Apr;230(4):842-52. doi: 10.1002/jcp.24812.

3.

Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism.

Sun L, Trausch-Azar JS, Muglia LJ, Schwartz AL.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3339-44. doi: 10.1073/pnas.0800165105. Epub 2008 Feb 22.

4.

In vivo interactions of MyoD, Id1, and E2A proteins determined by acceptor photobleaching fluorescence resonance energy transfer.

Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL.

FASEB J. 2008 Jun;22(6):1694-701. doi: 10.1096/fj.07-095000. Epub 2008 Jan 15.

PMID:
18198216
5.

E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation.

Sun L, Trausch-Azar JS, Ciechanover A, Schwartz AL.

Oncogene. 2007 Jan 18;26(3):441-8. Epub 2006 Aug 7.

PMID:
16909127
6.

E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1.

Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL.

Oncogene. 2005 Sep 22;24(42):6376-84.

PMID:
16007194
7.

Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and Id1 during muscle differentiation.

Sun L, Trausch-Azar JS, Ciechanover A, Schwartz AL.

J Biol Chem. 2005 Jul 15;280(28):26448-56. Epub 2005 May 11.

8.

Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD.

Trausch-Azar JS, Lingbeck J, Ciechanover A, Schwartz AL.

J Biol Chem. 2004 Jul 30;279(31):32614-9. Epub 2004 May 25.

9.

Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD.

Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL.

J Biol Chem. 2003 Jan 17;278(3):1817-23. Epub 2002 Oct 22.

10.

The nuclear ubiquitin-proteasome system degrades MyoD.

Floyd ZE, Trausch-Azar JS, Reinstein E, Ciechanover A, Schwartz AL.

J Biol Chem. 2001 Jun 22;276(25):22468-75. Epub 2001 Apr 17.

12.

Identification of a region within the ubiquitin-activating enzyme required for nuclear targeting and phosphorylation.

Stephen AG, Trausch-Azar JS, Handley-Gearhart PM, Ciechanover A, Schwartz AL.

J Biol Chem. 1997 Apr 18;272(16):10895-903.

13.

The ubiquitin-activating enzyme E1 is phosphorylated and localized to the nucleus in a cell cycle-dependent manner.

Stephen AG, Trausch-Azar JS, Ciechanover A, Schwartz AL.

J Biol Chem. 1996 Jun 28;271(26):15608-14.

14.

Human ubiquitin-activating enzyme, E1. Indication of potential nuclear and cytoplasmic subpopulations using epitope-tagged cDNA constructs.

Handley-Gearhart PM, Stephen AG, Trausch-Azar JS, Ciechanover A, Schwartz AL.

J Biol Chem. 1994 Dec 30;269(52):33171-8.

15.
16.

Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent.

Grenfell SJ, Trausch-Azar JS, Handley-Gearhart PM, Ciechanover A, Schwartz AL.

Biochem J. 1994 Jun 15;300 ( Pt 3):701-8.

Supplemental Content

Loading ...
Support Center